Loading organizations...
§ Private Profile · Vancouver, BC, Canada
PHEMI is a technology company.
PHEMI Systems offers the PHEMI Health DataLab, a big data management platform. It enables organizations to derive insights from vast datasets, integrating military-grade privacy, security, and governance for compliant use. The platform simplifies data management and de-identification, facilitating secure analysis of healthcare data adhering to regulatory standards.
PHEMI Health Systems was co-founded in 2013 by Dr. Alan Rabinowitz, Dr. Paul Terry, Adam Lorant, John Seminerio, and Chris Thompson. Dr. Rabinowitz, Chief Medical Officer, provides medical insight; Dr. Terry, a serial entrepreneur, co-founded OctigaBay Systems. This team identified healthcare's critical need to securely leverage patient data, inspiring their platform's balance of utility and privacy.
Serving healthcare organizations, PHEMI’s platform improves clinical productivity and patient outcomes through secure data utilization. It empowers institutions to drive innovation and extract value from health data, upholding privacy protocols. PHEMI envisions healthcare data as a trustworthy, accessible asset, accelerating medical understanding and patient care.
PHEMI has raised $25.0M across 4 funding rounds.
PHEMI has raised $25.0M in total across 4 funding rounds.
PHEMI has raised $25.0M across 4 funding rounds. Most recently, it raised $3.0M Series U in August 2018.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 1, 2018 | $3M Series U | — | Amplitude VC | Announced |
| Jun 1, 2017 | $10M Series B | BDC Capital, CTI Life Sciences Fund, GF Securities, Karimah ES Sabar | Amplitude VC | Announced |
| Aug 1, 2015 | $9M Series A | Charles Cook, Shermaine Tilley | Amplitude VC, BDC Capital | Announced |
| Mar 1, 2014 | $3M Seed | — | Amplitude VC, Dion Madsen | Announced |
PHEMI has raised $25.0M in total across 4 funding rounds.
PHEMI's investors include Amplitude VC, BDC Capital, CTI Life Sciences Fund, GF Securities, Karimah Es Sabar, Charles Cook, Shermaine Tilley, Dion Madsen.
PHEMI is a Vancouver-based technology company specializing in cloud-based big data management platforms for the healthcare sector.[1] Its core product, the PHEMI Trustworthy Health DataLab (also known as PHEMI Data Privacy Manager), enables secure ingestion, de-identification, governance, and sharing of sensitive healthcare data while ensuring compliance with privacy regulations.[1][2] The platform serves researchers, scientists, clinicians, and healthcare organizations by solving the challenge of accessing and analyzing "stranded" volumes of data for insights that lower costs, improve outcomes, and accelerate decisions, with optimizations for Microsoft Azure and flexible usage-based pricing.[1][2] Founded in 2013, PHEMI has raised $20.15M in funding (last round $750K seven years ago) and remains in the grant/alive stage, focusing on privacy-by-design with NSA-grade security down to the single-cell level without sacrificing performance.[1][2]
PHEMI was founded in 2013 in Vancouver, British Columbia, at 157 Alexander St, Suite 300.[1] While specific founders are not detailed in available sources, the company emerged to tackle big data challenges in healthcare, pioneering privacy, security, and governance for stranded data volumes.[1][2] Early traction centered on its turnkey platform for data lifecycle management—from acquisition and cataloging to analytics-ready datasets—positioning it as a Privacy by Design ambassador amid rising demands for compliant data collaboration.[2] By addressing integration complexities and high costs of fragmented tools, PHEMI gained momentum in healthcare, raising $20.15M across rounds, with its last known funding of $750K about seven years ago.[1]
PHEMI rides the wave of healthcare big data explosion, where regulations like HIPAA and GDPR demand trustworthy platforms amid rising AI-driven analytics needs.[1][2] Its timing aligns with cloud adoption (e.g., Azure) and Privacy by Design principles, countering market forces like data silos, cyber threats, and compliance costs that strand valuable insights.[2] By enabling secure collaboration, PHEMI influences the ecosystem, empowering researchers and clinicians to drive outcomes in precision medicine and population health, distinct from broader data tools by prioritizing healthcare-specific governance.[1]
PHEMI's stalled funding since ~2018 and "alive" status suggest a pivot toward sustainability via Azure partnerships and enterprise scaling, potentially reigniting growth in AI-healthcare intersections.[1] Trends like federated learning, zero-trust data sharing, and global privacy laws will shape its path, amplifying demand for granular security. Its influence could evolve from niche innovator to key enabler in collaborative health data ecosystems, unlocking stranded data's full value if it navigates funding droughts and competition. This positions PHEMI as a quiet force in secure big data, echoing its founding mission to simplify insights without compromise.[1][2]